Euroapi SAS
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry;… Read more
Euroapi SAS (EAPI) - Total Assets
Latest total assets as of June 2025: €1.44 Billion EUR
Based on the latest financial reports, Euroapi SAS (EAPI) holds total assets worth €1.44 Billion EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Euroapi SAS - Total Assets Trend (2019–2024)
This chart illustrates how Euroapi SAS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Euroapi SAS - Asset Composition Analysis
Current Asset Composition (December 2024)
Euroapi SAS's total assets of €1.44 Billion consist of 55.7% current assets and 44.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €73.00 Million | 4.9% |
| Accounts Receivable | €161.30 Million | 10.8% |
| Inventory | €524.20 Million | 35.2% |
| Property, Plant & Equipment | €529.30 Million | 35.5% |
| Intangible Assets | €38.10 Million | 2.6% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Euroapi SAS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Euroapi SAS's current assets represent 55.7% of total assets in 2024, a decrease from 61.8% in 2019.
- Cash Position: Cash and equivalents constituted 4.9% of total assets in 2024, up from -1.3% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is property, plant & equipment at 35.5% of total assets.
Euroapi SAS Competitors by Total Assets
Key competitors of Euroapi SAS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Euroapi SAS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Euroapi SAS generates 0.62x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Euroapi SAS is currently not profitable relative to its asset base.
Euroapi SAS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.53 | 1.57 | 2.89 |
| Quick Ratio | 0.80 | 0.70 | 1.15 |
| Cash Ratio | 0.17 | 0.38 | 0.00 |
| Working Capital | €476.00 Million | € 419.80 Million | € 639.90 Million |
Euroapi SAS - Advanced Valuation Insights
This section examines the relationship between Euroapi SAS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.22 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -7.6% |
| Total Assets | €1.49 Billion |
| Market Capitalization | $65.91 Million USD |
Valuation Analysis
Below Book Valuation: The market values Euroapi SAS's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Euroapi SAS's assets decreased by 7.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Euroapi SAS (2019–2024)
The table below shows the annual total assets of Euroapi SAS from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €1.49 Billion | -7.62% |
| 2023-12-31 | €1.61 Billion | -7.13% |
| 2022-12-31 | €1.74 Billion | +7.27% |
| 2021-12-31 | €1.62 Billion | +1.09% |
| 2020-12-31 | €1.60 Billion | +1.54% |
| 2019-12-31 | €1.58 Billion | -- |